Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - DUSA PHARMACEUTICALS INCFinancial_Report.xls
10-K - FORM 10-K - DUSA PHARMACEUTICALS INCd302702d10k.htm
EX-3.(B) - AMENDED AND RESTATED BY-LAWS OF THE REGISTRANT - DUSA PHARMACEUTICALS INCd302702dex3b.htm
EX-23.(A) - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - DUSA PHARMACEUTICALS INCd302702dex23a.htm
EX-31.(A) - RULE 13A-14(A)/15D-14(A) CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - DUSA PHARMACEUTICALS INCd302702dex31a.htm
EX-31.(B) - RULE 13A-14(A)/15D-14(A) CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - DUSA PHARMACEUTICALS INCd302702dex31b.htm
EX-21.(A) - SUBSIDIARIES OF DUSA PHARMACEUTICALS, INC. - DUSA PHARMACEUTICALS INCd302702dex21a.htm
EX-99.1 - PRESS RELEASE - DUSA PHARMACEUTICALS INCd302702dex991.htm
EX-32.(A) - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 - DUSA PHARMACEUTICALS INCd302702dex32a.htm
EX-10.(H) - 2011 AMENDED AND RESTATED PURCHASE AND SUPPLY AGREEMENT - DUSA PHARMACEUTICALS INCd302702dex10h.htm

EXHIBIT 32(b)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of DUSA Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, Richard C. Christopher, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 6, 2012     /s/    Richard C. Christopher
    Richard C. Christopher
Vice President, Finance and Chief Financial Officer
(principal financial officer)